Xxera/openscience/retractions

Record #20170

Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies

Guy Lahat, Quan Sheng Zhu, Kai Lieh Huang, Suizhao Wang, Svetlana Bolshakov, Jeffrey Liu, Robert R Langley, Alexander J Lazar, Mien Chie Hung, Dina C Lev

Journal

Publisher

Original paper date

Apr 16, 2010

Original DOI

10.1371/journal.pone.0010105

Country

🇺🇸 United States

Institution

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America · Sarcoma Research Center, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America · Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America · Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America · Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (BLS) Biology - Cellular (BLS) Toxicology (HSC) Medicine - Oncology

Notes from Retraction Watch

see also: https://pubpeer.com/publications/B0C3E8A174168169E76500DD0F49B3

Citation lifecycle

How this paper is being cited

Pre-retraction

134

Same day

1

Post-retraction

26

% post-retraction

16.1%

~15.0 citations/yr before retraction · ~3.5 citations/yr after

— citing papers

Who is still citing this work

Loading…